Northwest Biotherapeutics reported 7.87M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Agenus AGEN:US $ 18.95M 3.02M
Applied Genetic Technologies AGTC:US $ 4.32M 494K
AstraZeneca AZN:LN 3.06B 1.03B
Bristol Myers Squibb BMY:US $ 1.83B 523M
Celldex Therapeutics CLDX:US $ 6.91M 670K
Cti Biopharma CTIC:US $ 18.05M 6.65M
Cytori Therapeutics CYTX:US $ 2.14M 99K
Cytrx CYTR:US 51.91K 1.93M
Eisai 4523:JP 110.49B 9.03B
Genocea Biosciences GNCA:US $ 3.6M 473K
Infinity Pharmaceuticals INFI:US 3.68M 413K
Merk MRK:US $ 2.3B 518M
Mirati Therapeutics MRTX:US $ 53.95M 10.42M
Northwest Biotherapeutics NWBO:US 7.87M 1.38M